Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 1974
TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349630(US10208011, Compound RAD- | US10981887, Compound R...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349629(sodium 1-(2-(4-(2-(4-fluoro-2,6- dimethylbenzoyl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349630(US10208011, Compound RAD- | US10981887, Compound R...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349627((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349625((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349626((4-f1uoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349629(sodium 1-(2-(4-(2-(4-fluoro-2,6- dimethylbenzoyl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349628((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (4-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349606((3-(4-(2-(ethylamino)ethyl)phenoxy)-6- hydroxybenz...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349607((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349606((3-(4-(2-(ethylamino)ethyl)phenoxy)-6- hydroxybenz...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349608((3-(4-(azepan-1-yl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349607((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349608((3-(4-(azepan-1-yl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349614((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349615((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349613((3-(4-(2-(azepan-1-yl)ethoxy)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349614((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349616((3-(4-(2- (cyclohexylamino)ethyl)phenoxy)-6- hydro...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349617((3-(4-(2-(sec- butylamino)ethyl)phenoxy)-6- hydrox...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349615((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349616((3-(4-(2- (cyclohexylamino)ethyl)phenoxy)-6- hydro...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349610((3-(4-(2-aminoethyl)phenoxy)-6- hydroxybenzo[b]thi...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349609((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349610((3-(4-(2-aminoethyl)phenoxy)-6- hydroxybenzo[b]thi...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349612((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349613((3-(4-(2-(azepan-1-yl)ethoxy)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349611((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349612((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349622((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(3- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349623((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349621((3-(4-(aminomethyl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349622((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(3- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349624((S)-(4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349625((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349623((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349624((S)-(4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349618((3-(4-(2-(diethylamino)ethyl)phenoxy)-6- hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349619((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4- ((m...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349617((3-(4-(2-(sec- butylamino)ethyl)phenoxy)-6- hydrox...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349618((3-(4-(2-(diethylamino)ethyl)phenoxy)-6- hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349620((3-(4-((dimethylamino)methyl)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349621((3-(4-(aminomethyl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349619((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4- ((m...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349620((3-(4-((dimethylamino)methyl)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349609((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 5.00E+4nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349626((4-f1uoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 5.00E+4nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349611((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2- ...)
Affinity DataIC50: 5.00E+4nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349628((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (4-(fluorom...)
Affinity DataIC50: 5.00E+4nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent

TargetG-protein coupled estrogen receptor 1(Human)
G1 Therapeutics

US Patent
LigandPNGBDBM349627((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 5.00E+4nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences # IB00401. In an effort to screen selective e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent